Xeris Biopharma Holdings, Inc. number of employees

Xeris Biopharma Holdings, Inc. reported 435 employees at December 31, 2025 in its latest annual report. Revenue per employee was $670,908.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	435	—	$670,908	10-K, filed March 2, 2026

What the annual reports say

Human Capital Resources As of December 31, 2025, we had 435 full-time employees in the United States, 216 of whom were primarily engaged in sales and marketing, 169 of whom were primarily engaged in general administration, and 50 of whom were primarily engaged in product development and research. 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: EOLS vs XERS IRWD vs XERS INVA vs XERS

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Xeris Biopharma Holdings, Inc.